[Remote] Principal Software Engineer at Genesis Therapeutics

New York, New York, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, Pharmaceuticals, Artificial Intelligence, Drug DiscoveryIndustries

Skills

Key technologies and capabilities for this role

Software ArchitectureMachine LearningData InfrastructureAPIsPythonMolecular DynamicsQuantum ChemistryBiophysical SimulationComputational ChemistryC++Cloud Computing

Questions & Answers

Common questions about this position

What is the location arrangement for this role?

The position is hybrid.

What benefits are offered?

Benefits include medical, dental, and vision insurance, a 401(k) program, competitive salary and equity, and weekly reading and discussion of machine learning or chemistry papers.

What skills and experience are required for this Principal Software Engineer role?

Key requirements include deep thinking from first principles, balancing detail with architecture, investigational curiosity, comfort across the full software stack, building intuitive APIs, mastery of production code, and a strong background in both chemistry and computer science.

What is the company culture like at Genesis Therapeutics?

The culture features strong technical coworkers in AI, software, and chemistry, weekly discussions of machine learning or chemistry papers, and a collaborative environment where engineers from chemistry and computer science backgrounds work together on high-impact drug discovery tools.

What makes a strong candidate for this position?

A strong candidate has strengths as a technical lead and software architect, experience in both chemistry and computer science, and the ability to lead, mentor, and coach engineers while scaling data infrastructure.

Genesis Therapeutics

AI-driven drug discovery for pharmaceuticals

About Genesis Therapeutics

Genesis Therapeutics accelerates the development of new medicines by using artificial intelligence in drug discovery. The company combines 3D spatial graph modeling and molecular simulation to identify potential drug candidates and explore new chemical spaces. Unlike its competitors, Genesis Therapeutics focuses on strategic partnerships with other biotech and pharmaceutical companies, generating revenue through upfront payments and future earnings based on drug success. The goal is to transform the drug discovery process and bring new therapies to market.

Burlingame, CaliforniaHeadquarters

2019Year Founded

$272.5MTotal Funding

SERIES_BCompany Stage

AI & Machine Learning, BiotechnologyIndustries

51-200Employees

Benefits

Competitive salary

Equity

Medical, dental, & vision insurance

401(k) program

Risks

Competition from AI-driven companies like Insilico Medicine and Exscientia is increasing.

Over-reliance on partnerships could lead to financial instability if drugs aren't successful.

Rapid AI advancements may render current models like GEMS obsolete without updates.

Differentiation

Genesis Therapeutics uses AI to accelerate drug discovery with 3D spatial graph modeling.

The GEMS platform integrates deep learning, molecular simulations, and generative AI for drug design.

Strategic partnerships with Eli Lilly and Gilead highlight Genesis' industry collaboration strength.

Upsides

Partnership with NVIDIA enhances GEMS platform for targeting undruggable diseases.

$224 million equity investment boosts research and development capabilities.

Recognition as a 'Fierce 15' company underscores AI's role in breakthrough therapeutics.

Land your dream remote job 3x faster with AI

Try Jobo Free